Evidence map›Paper›PMID 38291503›Full record

ArticleGenome biology2024

deMULTIplex2: robust sample demultiplexing for scRNA-seq.

Qin Zhu, Daniel N Conrad, Zev J Gartner

Abstract read
In one paragraph

Article in Genome biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. A unified genetic perturbation language for human cellular programming.bioRxiv : the preprint server for biology · 2025
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Qin ZhuDepartment of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA, 94158, USA. qin.zhu@ucsf.edu.
Daniel N ConradDepartment of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA, 94158, USA.
Zev J GartnerDepartment of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA, 94158, USA. zev.gartner@ucsf.edu.ORCID 0000-0001-7803-1219

Funding

The roles of regional specialization, mechanical forces and epigenetic memory after perturbation and injury of the intestinal stem cell microenvironmentU01DK103147 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KLEIN, OPHIR D · 2014 to 2023
$5.4M
The physical and molecular mechanisms of intestinal villus morphogenesis and repairR01DK126376 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Zev Jordan Gartner · 2020 to 2026
$4.2M
Integrative approach to heterogeneity in breast cancer metastasisU01CA199315 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GOGA, ANDREI, SPELLMAN, PAUL T. · 2016 to 2020
$3.2M
Understanding breast cancer progression as a defect in the mechanics of tissue self-organizationU01CA244109 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GARTNER, ZEV JORDAN, GOGA, ANDREI · 2020 to 2024
$3.0M
MULTIseq: multiplexing massively parallel single cell transcriptional analysis across time, space, and conditionsR01GM135462 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GARTNER, ZEV JORDAN · 2019 to 2022
$1.3M
Universal Sample Multiplexing for Single Cell AnalysisR33CA247744 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GARTNER, ZEV JORDAN · 2021 to 2023
$1.2M
Cancer Research Institute CRI5054NCI NIH HHS R33 CA247744NCI NIH HHS R33CA247744NCI NIH HHS U01 CA199315NCI NIH HHS U01CA199315NCI NIH HHS U01 CA244109NIDDK NIH HHS R01 DK126376NIDDK NIH HHS R01DK126376NIDDK NIH HHS U01 DK103147NIDDK NIH HHS U01DK103147NIGMS NIH HHS R01 GM135462NIGMS NIH HHS R01GM135462
6 · The paper itself

Abstract

Sample multiplexing enables pooled analysis during single-cell RNA sequencing workflows, thereby increasing throughput and reducing batch effects. A challenge for all multiplexing techniques is to link sample-specific barcodes with cell-specific barcodes, then demultiplex sample identity post-sequencing. However, existing demultiplexing tools fail under many real-world conditions where barcode cross-contamination is an issue. We therefore developed deMULTIplex2, an algorithm inspired by a mechanistic model of barcode cross-contamination. deMULTIplex2 employs generalized linear models and expectation-maximization to probabilistically determine the sample identity of each cell. Benchmarking reveals superior performance across various experimental conditions, particularly on large or noisy datasets with unbalanced sample compositions.

Indexed as

Single-Cell AnalysisSingle-Cell Gene Expression AnalysisAlgorithmsHigh-Throughput Nucleotide SequencingSequence Analysis, RNADemultiplexExpectation–maximizationGeneralized linear modelsSample multiplexingscRNA-seq

Identifiers

PMID38291503
PMCPMC10829271

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.